Who is sponsoring NCT05424445?

NCT05424445 is sponsored by Karolinska Institutet.

What condition does NCT05424445 study?

NCT05424445 studies Induced Vaginal Delivery.

What is the status of NCT05424445?

NCT05424445 is currently COMPLETED.

Last reviewed 2023-08-18 · How we verify

MISOBEST - Orally Misoprostol Solution (Cytotec®) Versus Orally Misoprostol as a Tablet (Angusta®) for Induction of Labor

NCT05424445 PHASE3 COMPLETED

The aim of the study is to evaluate efficacy of the cervical ripening of misoprostol administration in oral tablet, Angusta® compared with the off-label solution of misoprostol (Cytotec®) for induction of labor (IOL). Since there is a large cost difference between the preparations (Angusta® is 43 times more expensive than Cytotec®) it is, from a socio-economic perspective, of great interest to evaluate if Angusta can be replaced by Cytotec.

Details

Lead sponsor	Karolinska Institutet
Phase	PHASE3
Status	COMPLETED
Enrolment	884
Start date	Fri Jan 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Sun May 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Induced Vaginal Delivery

Interventions

Misoprostol

Countries

Sweden